346 related articles for article (PubMed ID: 28257827)
1. Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer.
Di Donato M; Cernera G; Giovannelli P; Galasso G; Bilancio A; Migliaccio A; Castoria G
Mol Cell Endocrinol; 2017 Dec; 457():35-42. PubMed ID: 28257827
[TBL] [Abstract][Full Text] [Related]
2. Preimplantation Exposure to Bisphenol A and Triclosan May Lead to Implantation Failure in Humans.
Yuan M; Bai MZ; Huang XF; Zhang Y; Liu J; Hu MH; Zheng WQ; Jin F
Biomed Res Int; 2015; 2015():184845. PubMed ID: 26357649
[TBL] [Abstract][Full Text] [Related]
3. Female exposure to endocrine disrupting chemicals and fecundity: a review.
Mínguez-Alarcón L; Gaskins AJ
Curr Opin Obstet Gynecol; 2017 Aug; 29(4):202-211. PubMed ID: 28557831
[TBL] [Abstract][Full Text] [Related]
4. A review on sources and health impacts of bisphenol A.
Abraham A; Chakraborty P
Rev Environ Health; 2020 Jun; 35(2):201-210. PubMed ID: 31743105
[TBL] [Abstract][Full Text] [Related]
5. Long-term oral exposure to safe dose of bisphenol A in association with high-fat diet stimulate the prostatic lesions in a rodent model for prostate cancer.
Facina CH; Campos SGP; Gonçalves BF; Góes RM; Vilamaior PSL; Taboga SR
Prostate; 2018 Feb; 78(2):152-163. PubMed ID: 29148069
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
Lee GA; Hwang KA; Choi KC
Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
[TBL] [Abstract][Full Text] [Related]
7. Could the endocrine disruptor bisphenol-A be implicated in the pathogenesis of oral and oropharyngeal cancer? Metabolic considerations and future directions.
Emfietzoglou R; Spyrou N; Mantzoros CS; Dalamaga M
Metabolism; 2019 Feb; 91():61-69. PubMed ID: 30458176
[TBL] [Abstract][Full Text] [Related]
8. Endocrine disrupting chemical Bisphenol A and its potential effects on female health.
Kawa IA; Akbar Masood ; Fatima Q; Mir SA; Jeelani H; Manzoor S; Rashid F
Diabetes Metab Syndr; 2021; 15(3):803-811. PubMed ID: 33839640
[TBL] [Abstract][Full Text] [Related]
9. The Endocrine Disruptor Bisphenol A (BPA) Exerts a Wide Range of Effects in Carcinogenesis and Response to Therapy.
Hafezi SA; Abdel-Rahman WM
Curr Mol Pharmacol; 2019; 12(3):230-238. PubMed ID: 30848227
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications associated with in utero exposure to endocrine disrupting chemicals BPA, DDT and Pb.
Onuzulu CD; Rotimi OA; Rotimi SO
Rev Environ Health; 2019 Dec; 34(4):309-325. PubMed ID: 31271561
[TBL] [Abstract][Full Text] [Related]
11. [Bisphenol A and hormone-dependent cancers: potential risk and mechanism].
Rochefort H
Med Sci (Paris); 2013 May; 29(5):539-44. PubMed ID: 23732105
[TBL] [Abstract][Full Text] [Related]
12. Fetal-Maternal Exposure to Endocrine Disruptors: Correlation with Diet Intake and Pregnancy Outcomes.
Rolfo A; Nuzzo AM; De Amicis R; Moretti L; Bertoli S; Leone A
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545151
[TBL] [Abstract][Full Text] [Related]
13. Oestrogenic Endocrine Disruptors in the Placenta and the Fetus.
Tang ZR; Xu XL; Deng SL; Lian ZX; Yu K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102189
[TBL] [Abstract][Full Text] [Related]
14. Computational insights into the molecular interactions of environmental xenoestrogens 4-tert-octylphenol, 4-nonylphenol, bisphenol A (BPA), and BPA metabolite, 4-methyl-2, 4-bis (4-hydroxyphenyl) pent-1-ene (MBP) with human sex hormone-binding globulin.
Sheikh IA; Tayubi IA; Ahmad E; Ganaie MA; Bajouh OS; AlBasri SF; Abdulkarim IMJ; Beg MA
Ecotoxicol Environ Saf; 2017 Jan; 135():284-291. PubMed ID: 27750096
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?
Barrett ES; Sobolewski M
Semin Reprod Med; 2014 May; 32(3):166-76. PubMed ID: 24715511
[TBL] [Abstract][Full Text] [Related]
16. BPA, an energy balance disruptor.
Le Corre L; Besnard P; Chagnon MC
Crit Rev Food Sci Nutr; 2015; 55(6):769-77. PubMed ID: 24915348
[TBL] [Abstract][Full Text] [Related]
17. Bisphenol A and hormone-associated cancers: current progress and perspectives.
Gao H; Yang BJ; Li N; Feng LM; Shi XY; Zhao WH; Liu SJ
Medicine (Baltimore); 2015 Jan; 94(1):e211. PubMed ID: 25569640
[TBL] [Abstract][Full Text] [Related]
18. Endocrine disruption: Molecular interactions of environmental bisphenol contaminants with thyroid hormone receptor and thyroxine-binding globulin.
Beg MA; Sheikh IA
Toxicol Ind Health; 2020 May; 36(5):322-335. PubMed ID: 32496146
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanisms of action of the endocrine disrupting chemical bisphenol A in the development of cancer.
Shafei A; Ramzy MM; Hegazy AI; Husseny AK; El-Hadary UG; Taha MM; Mosa AA
Gene; 2018 Mar; 647():235-243. PubMed ID: 29317319
[TBL] [Abstract][Full Text] [Related]
20. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects.
Rubin BS
J Steroid Biochem Mol Biol; 2011 Oct; 127(1-2):27-34. PubMed ID: 21605673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
